Answer
It is licensed with miglustat as enzyme replacement therapy for adults with late-onset Pompe disease.
Sources for this answer
- Pombiliti 105 mg powder for concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.